National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre (BRC), Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK.
Aliment Pharmacol Ther. 2018 Aug;48(3):322-332. doi: 10.1111/apt.14828. Epub 2018 Jun 8.
Liver transplantation is the only life-extending intervention for primary sclerosing cholangitis (PSC). Given the co-existence with colitis, patients may also require colectomy; a factor potentially conferring improved post-transplant outcomes.
To determine the impact of restorative surgery via ileal pouch-anal anastomosis (IPAA) vs retaining an end ileostomy on liver-related outcomes post-transplantation.
Graft survival was evaluated across a prospectively accrued transplant database, stratified according to colectomy status and type.
Between 1990 and 2016, 240 individuals with PSC/colitis underwent transplantation (cumulative 1870 patient-years until first graft loss or last follow-up date), of whom 75 also required colectomy. A heightened incidence of graft loss was observed for the IPAA group vs those retaining an end ileostomy (2.8 vs 0.4 per 100 patient-years, log-rank P = 0.005), whereas rates between IPAA vs no colectomy groups were not significantly different (2.8 vs 1.7, P = 0.1). In addition, the ileostomy group experienced significantly lower graft loss rates vs. patients retaining an intact colon (P = 0.044). The risks conferred by IPAA persisted when taking into account timing of colectomy as related to liver transplantation via time-dependent Cox regression analysis. Hepatic artery thrombosis and biliary strictures were the principal aetiologies of graft loss overall. Incidence rates for both were not significantly different between IPAA and no colectomy groups (P = 0.092 and P = 0.358); however, end ileostomy appeared protective (P = 0.007 and 0.031, respectively).
In PSC, liver transplantation, colectomy + IPAA is associated with similar incidence rates of hepatic artery thrombosis, recurrent biliary strictures and re-transplantation compared with no colectomy. Colectomy + end ileostomy confers more favourable graft outcomes.
肝移植是原发性硬化性胆管炎(PSC)唯一的延长生命的干预措施。鉴于与结肠炎并存,患者可能还需要结肠切除术;这一因素可能会带来更好的移植后效果。
确定通过回肠袋肛管吻合术(IPAA)进行修复性手术与保留末端回肠造口术对移植后肝脏相关结局的影响。
通过前瞻性累积移植数据库评估移植物存活率,根据结肠切除术的状态和类型进行分层。
1990 年至 2016 年间,240 名 PSC/结肠炎患者接受了移植(累积 1870 名患者年,直到首次移植物丢失或最后随访日期),其中 75 名患者还需要结肠切除术。与保留末端回肠造口术相比,IPAA 组的移植物丢失发生率更高(每 100 患者年 2.8 比 0.4,对数秩检验 P=0.005),而 IPAA 与无结肠切除术组之间的差异无统计学意义(2.8 比 1.7,P=0.1)。此外,与保留完整结肠的患者相比,回肠造口术组的移植物丢失率显著降低(P=0.044)。通过时间依赖性 Cox 回归分析考虑到结肠切除术与肝移植的时间关系,IPAA 带来的风险仍然存在。总的来说,肝动脉血栓形成和胆管狭窄是移植物丢失的主要病因。在 IPAA 和无结肠切除术组之间,这两种病因的发生率差异均无统计学意义(P=0.092 和 P=0.358);然而,末端回肠造口术似乎具有保护作用(P=0.007 和 0.031)。
在 PSC 中,与无结肠切除术相比,肝移植、结肠切除术+IPAA 与肝动脉血栓形成、复发性胆管狭窄和再次移植的发生率相似。结肠切除术+末端回肠造口术可获得更好的移植物结局。